- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Sectors
Jasper Therapeutics jumps at reverse merger opportunity
The stem cell-transplant technology developer, partly based on Stanford research, is going public through a reverse merger that will give it a $490m market capitalisation.
May 10, 2021Waterdrop mops up $360m in IPO
The Meituan Dianping, Tencent and Swiss Re-backed health insurance marketplace operator priced its offering at the top of its range.
May 10, 2021Gojek calls in $300m from Telkmosel
Existing investor Telkomsel provided the cash as on-demand ride provider Gojek prepares to seal a merger with e-commerce platform Tokopedia at an $18bn valuation.
May 10, 2021Jasper Therapeutics jumps at reverse merger opportunity
Roche Venture Fund and Amgen will invest in the stem cell-transplant technology developer through a reverse merger transaction which will give it a $490m market capitalisation.
May 10, 2021Science 37 experiments with reverse takeover
The Sanofi, Amgen, Alphabet, Novartis and PPD-backed clinical trials software producer is joining forces with publicly listed LifeSci Acquisition II Corp.
May 10, 2021AMS takes care of over $100m
Kaiser Permanente has helped the parent company of in vitro diagnostics test provider ET Healthcare and biotechnology developer Gator Bio close its latest round.
May 10, 2021Gyroscope Therapeutics gives up $149m IPO
The Fosun-backed gene therapy developer had set terms for an offering set to raise between $135m and $149m on the Nasdaq Global Select Market.
May 10, 2021Alebund aligns with $60m
Lilly Asia Ventures was among the investors in a series B round for the renal disease treatment developer, which it incubated in 2018.
May 10, 2021Corporates illuminate Lightmatter in $80m series B
Alphabet, Hewlett Packard Enterprise and Lockheed Martin invested in the photonic computing technology developer’s series B round, increasing its total funding to $113m.
May 10, 2021Sprout.ai grows with $11m series A
Founded at Imperial Collge London, Sprout three years ago, Sprout.ai has now secured $11m in a series A round led by Octopus Ventures.
May 10, 2021Analysis: Solid Power with a $130m recharge
Solid-state battery developer Solid Power secured a $130 series B round co-led by its potential customers from the automotive sector BMW and Ford Motor Company.
May 10, 2021Yikon Genomics picks up series D funding
The genome sequencing technology provider has boosted its total funding to approximately $124m, Sinopharm and China General Technology Group having backed a $38.7m round.
May 10, 2021Featured Content
GCV Powerlist 2026Nominations for the 2026 GCV Powerlist are now open. Use this form to nominate yourself or someone else.GCV Powerlist 2026
Nominations for the 2026 GCV Powerlist are now open. Use this form to nominate yourself or someone else.
The World of Corporate VenturingGCV's annual report on the state of the corporate investment sectorThe World of Corporate Venturing
GCV's annual report on the state of the corporate investment sector
GCV’s Rising Stars and Emerging Leaders 2026The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.GCV’s Rising Stars and Emerging Leaders 2026
The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
